BTC Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.37M | Buy |
92,514
+6,746
| +8% | +$413K | 0.62% | 57 |
|
|
2023
Q2 | $5.48M | Buy |
85,768
+1,402
| +2% | +$94K | 0.59% | 55 |
|
|
2023
Q1 | $5.8M | Buy |
84,366
+29,576
| +54% | +$2.09M | 0.67% | 51 |
|
|
2022
Q4 | $3.94M | Buy |
54,790
+1,301
| +2% | +$98.1K | 0.47% | 77 |
|
|
2022
Q3 | $3.8M | Buy |
53,489
+3,385
| +7% | +$246K | 0.5% | 72 |
|
|
2022
Q2 | $3.86M | Buy |
50,104
+1,943
| +4% | +$148K | 0.47% | 73 |
|
|
2022
Q1 | $3.52M | Sell |
48,161
-7,184
| -13% | -$482K | 0.35% | 87 |
|
|
2021
Q4 | $3.45M | Sell |
55,345
-27,070
| -33% | -$1.59M | 0.34% | 86 |
|
|
2021
Q3 | $4.88M | Sell |
82,415
-3,840
| -4% | -$253K | 0.55% | 61 |
|
|
2021
Q2 | $5.79M | Sell |
86,255
-12,681
| -13% | -$827K | 0.66% | 48 |
|
|
2021
Q1 | $6.25M | Buy |
98,936
+10,672
| +12% | +$664K | 0.7% | 46 |
|
|
2020
Q4 | $5.47M | Buy |
88,264
+15,169
| +21% | +$933K | 0.65% | 53 |
|
|
2020
Q3 | $4.41M | Buy |
73,095
+2,735
| +4% | +$165K | 0.62% | 59 |
|
|
2020
Q2 | $4.14M | Sell |
70,360
-1,309
| -2% | -$78.3K | 0.63% | 60 |
|
|
2020
Q1 | $4M | Sell |
71,669
-13,970
| -16% | -$854K | 0.76% | 47 |
|
|
2019
Q4 | $5.48M | Buy |
85,639
+797
| +0.9% | +$45.6K | 0.78% | 42 |
|
|
2019
Q3 | $4.3M | Sell |
84,842
-464
| -0.5% | -$21.8K | 0.69% | 53 |
|
|
2019
Q2 | $3.87M | Buy |
85,306
+1,132
| +1% | +$52.7K | 0.63% | 56 |
|
|
2019
Q1 | $4.01M | Buy |
84,174
+42,299
| +101% | +$2.11M | 0.64% | 57 |
|
|
2018
Q4 | $2.18M | Buy |
+41,875
| New | +$2.25M | 0.39% | 89 |
|
|
2018
Q3 | – | Sell |
-4,253
| Closed | -$234K | – | 173 |
|
|
2018
Q2 | $234K | Buy |
4,253
+800
| +23% | +$43.2K | 0.06% | 136 |
|
|
2018
Q1 | $218K | Hold |
3,453
| – | – | 0.04% | 174 |
|
|
2017
Q4 | $211K | Buy |
+3,453
| New | +$216K | 0.04% | 166 |
|
|
2017
Q1 | – | Sell |
-3,453
| Closed | -$201K | – | 173 |
|
|
2016
Q4 | $201K | Buy |
+3,453
| New | +$189K | 0.04% | 173 |
|
|
2016
Q3 | – | Sell |
-3,646
| Closed | -$269K | – | 171 |
|
|
2016
Q2 | $269K | Buy |
3,646
+283
| +8% | +$20K | 0.06% | 133 |
|
|
2016
Q1 | $215K | Buy |
+3,363
| New | +$212K | 0.05% | 149 |
|
|
2015
Q2 | – | Sell |
-47,030
| Closed | -$3.03M | – | 162 |
|
|
2015
Q1 | $3.03M | Sell |
47,030
-4,650
| -9% | -$291K | 0.7% | 47 |
|
|
2014
Q4 | $3.05M | Sell |
51,680
-2,475
| -5% | -$140K | 0.76% | 45 |
|
|
2014
Q3 | $2.77M | Buy |
+54,155
| New | +$2.71M | 0.7% | 56 |
|
Other funds holding BMY
BTC Capital Management's BMY Position: Q3 2023 in Review
BTC Capital Management increased its Bristol-Myers Squibb (BMY) stake by 7.9% in Q3 2023, buying an estimated $413K and bringing the position to 92,514 shares worth $5.37M. The position accounts for 0.62% of the portfolio, ranked #57.
BTC Capital Management first reported a position in BMY in Q3 2014 and has held it in 29 quarters since. The position peaked at $6.25M in Q1 2021. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- BTC Capital Management held 92,514 shares of Bristol-Myers Squibb worth $5.37M as of Q3 2023.
- BTC Capital Management bought 6,746 Bristol-Myers Squibb shares in Q3 2023, an estimated $413K.
- Bristol-Myers Squibb made up 0.62% of BTC Capital Management's portfolio in Q3 2023, its #57 holding.
- BTC Capital Management first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 29 quarters since.
- BTC Capital Management's Bristol-Myers Squibb position peaked at $6.25M in Q1 2021.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on BTC Capital Management's 13F filing for Q3 2023, filed 17 Oct 2023.